A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：7
|
作者：
DEGARDIN, M
DOMENGE, C
CAPPELAERE, P
LUBOINSKI, B
NAVARRETE, MS
SCOTT, JE
LEFEBVRE, JL
机构：
[1] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
[2] SERV RECH CLIN,LAB WELLCOME,F-92442 ISSY MOULINEAUX,FRANCE
[3] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 07期
关键词：
D O I：
10.1016/0959-8049(94)90156-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1044 / 1045
页数：2
相关论文
共 50 条
  • [21] PHASE-II STUDY OF MITOXANTRONE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    WILLIAMS, SD
    BIRCH, R
    VELEZGARCIA, E
    GAMS, R
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (03) : 311 - 313
  • [22] A PHASE-II STUDY OF LEVOFOLINIC ACID AND 5-FLUOROURACIL PLUS CISPLATIN IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    GEBBIA, V
    TESTA, A
    VALENZA, R
    ZERILLO, G
    RESTIVO, S
    CUPIDO, G
    INGRIA, F
    BARBACCIA, C
    SPADAFORA, G
    CANNATA, G
    GEBBIA, N
    ONCOLOGY, 1993, 50 (06) : 490 - 494
  • [23] PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    SLEDGE, GW
    CLARK, GM
    GRIFFIN, C
    MATTOX, DE
    VONHOFF, DD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 209 - 211
  • [24] PHASE-II STUDY OF AMINOTHIADIAZOLE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
    ENGSTROM, PF
    RYAN, LM
    FALKSON, G
    HALLER, DG
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (01): : 33 - 35
  • [25] PHASE-II TRIAL OF HOMOHARRINGTONINE (HHT) IN SQUAMOUS-CELL CARCINOMA OF THE HEAD NECK (SCCHN)
    DIMERY, IW
    LEGHA, S
    GOEPFERT, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 181 - 181
  • [26] PHASE-II TRIAL OF ICRF-187 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    WHEELER, RH
    BRICKER, LJ
    NATALE, RB
    BAKER, SR
    CANCER TREATMENT REPORTS, 1984, 68 (02): : 427 - 428
  • [27] PHASE-II STUDY OF ORAL MILTEFOSINE IN PATIENTS WITH SQUAMOUS-CELL HEAD AND NECK-CANCER
    VERWEIJ, J
    GANDIA, D
    PLANTING, AST
    STOTER, G
    ARMAND, JP
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 778 - 779
  • [28] PHASE-II CLINICAL-TRIAL WITH IFOSFAMIDE (IFX) IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    BUESA, JM
    FERNANDEZ, R
    ESTEBAN, E
    ALONSO, R
    ESTRADA, E
    GRACIA, M
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 73 - 73
  • [29] A PHASE-II STUDY OF CISPLATIN AND CYTOSINE-ARABINOSIDE FOR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BERNSTEIN, JI
    JACOBS, C
    MEYERS, F
    RICHGOFFINET, L
    TANAKA, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 58 - 60
  • [30] PHASE-II TRIAL WITH CARBOPLATIN/5-FU FOR PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    VOLLING, P
    SCHRODER, M
    RAUSCHNING, W
    ACHTERRATH, W
    STENNERT, E
    NAGEL, G
    HNO, 1988, 36 (11) : 452 - 455
12345